Horizon Pharma reported $949.14M in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US USD 15.69B 1.36B
AstraZeneca AZN:LN USD 26.29B 1.44B
Cara Therapeutics CARA:US USD 23.46M 4.73M
Coherus Biosciences CHRS:US USD 138.69M 32.62M
Endo International Ordinary Shares ENDP:US USD 543.05M 638.62M
Horizon Pharma HZNP:US USD 949.14M 88.52M
JAZZ PHA JAZZ:US USD 933.19M 120.24M
Novartis NOVN:VX USD 28.66B 496M
Pacira Pharmaceuticals PCRX:US USD 147.77M 16.25M
Perrigo Ordinary Shares PRGO:US USD 1.11B 98.6M
Prestige Brands PBH:US USD 160.18M 7.87M
Revance Therapeutics RVNC:US USD 75.68M 950K
Supernus Pharmaceuticals SUPN:US USD 687.96M 38.03M
Takeda 4502:JP JPY 2.24T 154.91B
Teva Pharmaceutical Industries TEVA:US USD 11.47B 65M
Valeant Pharmaceuticals VRX:CN USD 3.94B 110M
Xeris Pharmaceuticals Inc XERS:US USD 73.62M 5.06M
Zoetis ZTS:US USD 3.17B 287M